Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.
BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.
"We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.
"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.
In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.
We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.